ISSN: 1300-7777 E-ISSN: 1308-5263
Therapeutic apheresis in hematopoietic cell transplantation [Turk J Hematol]
Turk J Hematol. 2008; 25(4): 164-171

Therapeutic apheresis in hematopoietic cell transplantation

Nina Worel1, Gerda Leitner1, Andrea Wagner1, Hildegard T Greinix2, Paul Höcker1, Peter Kalhs2
1Department For Blood Group Serology And Transfusion Medicine, Medical University Of Vienna, Austria
2First Medical Department, Bone Marrow Transplantation

With the introduction of hematopoietic stem cell transplant (HSCT), transplant-associated problems like graft-versus-host disease (GVHD) and transplant-associated microangiopathy (TAM) have occurred. In addition, approximately 40% of allogeneic HSCTs are performed across the ABO blood group barrier, bearing the risk for immunohematological complications like severe hemolysis and pure red cell aplasia (PRCA). All these problems can potentially require therapeutic apheresis. In this review, we address recent developments in therapeutic apheresis for patients undergoing allogeneic HSCT for prevention or treatment of hemolysis in minor ABO-incompatible transplantation, treatment of PRCA after major ABO-incompatible transplantation, and treatment of TAM and GVHD.

Keywords: Stem cell transplantation, therapeutic apheresis, hemolysis, pure red cell aplasia, thrombotic microangiopathy, graft-versus-host disease


Hematopoetik kök hücre transplantasyonunda terapotik aferez

Nina Worel1, Gerda Leitner1, Andrea Wagner1, Hildegard T Greinix2, Paul Höcker1, Peter Kalhs2
1Department For Blood Group Serology And Transfusion Medicine, Medical University Of Vienna, Austria
2First Medical Department, Bone Marrow Transplantation

Hematopoetik kök hücre transplantasyonunun uygulanmasıyla Graft-versus-host hastalığı (GVHH) gibi transplanta bağlı problemler ve transplanta bağlı mikroanjiyopati (TAM) ortaya çıkmıştır. Ayrıca, allojenik HSCT’lerin yaklaşık %40’ı, şiddetli hemoliz ve saf kırmızı hücre aplazisi (PRCA) gibi immünohematolojik komplikasyon riski taşıyan ABO kan grubu karşın gerçekleştirilmiştir. Tüm bu problemler potansiyel olarak terapötik aferez gerektirebilir. Minör ABO uyumsuz transplantasyonda hemolizin tedavisi veya önlenmesi, majör ABO uyumsuz transplantasyon sonrası PRCA tedavisi ve TAM ve GVHH tedavisi için allojeneik HKHT uygulanan hastalara yönelik terapötik aferez ile ilgili en son gelişmeler bu değerlendirmede ele alınmaktadır.

Anahtar Kelimeler: Kök hücre transplantasyonu, terapötik aferez, hemoliz, saf kırmızı hücre aplazisi, trombotik mikroanjiyopati, graft-versus host hastalığı


Nina Worel, Gerda Leitner, Andrea Wagner, Hildegard T Greinix, Paul Höcker, Peter Kalhs. Therapeutic apheresis in hematopoietic cell transplantation. Turk J Hematol. 2008; 25(4): 164-171

Corresponding Author: Nina Worel, Austria


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar


 



Impact Factor (2017) = 0.650